139 results match your criteria: "Humanitas Clinical and Research Institute[Affiliation]"

Article Synopsis
  • Intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy occurs in 22% to 47%, prompting the need for effective intravesical chemotherapy, which remains underused due to safety and efficacy concerns.
  • A systematic review analyzed 18 studies with 2,483 patients, finding that intravesical chemotherapy significantly lowered the risk of recurrence at 12 months (OR=0.46) and 24 months (OR=0.41) after surgery.
  • The study highlighted a favorable safety profile for intravesical chemotherapy, showing only 9% minor and 0.9% major complications, while the optimal instillation methods require further investigation.
View Article and Find Full Text PDF
Article Synopsis
  • Surgery is the standard treatment for primary renal cell carcinoma (RCC), but stereotactic body radiotherapy (SBRT) is being explored as an alternative, particularly for patients who cannot or choose not to undergo surgery.
  • A systematic review of 13 studies showed that SBRT resulted in high local control (98% at one year) and overall survival rates (95% at one year), with low rates of serious adverse events (3%).
  • However, the studies had limitations such as short follow-up periods and inconsistent reporting of kidney function, indicating that more research is needed to evaluate its long-term effectiveness.
View Article and Find Full Text PDF

The Hugo™ Robotic-Assisted Surgery (Hugo™ RAS) system represents a novel advancement in robotic surgical technology. Despite this, there remains a scarcity of data regarding extraperitoneal robot-assisted radical prostatectomy (eRARP) using this system. We conducted a prospective study at Ospedale Regionale "F.

View Article and Find Full Text PDF

Purpose: Previous studies have demonstrated an association between video-gaming experience (VGE) and improved robotics skills. We aimed to evaluate the initial learning curve for the Ily® robotics system (Sterlab, Sophia Antipolis, France) when applied to flexible ureteroscopy (FU) among both medical students and urology surgeons.

Methods: There were two groups, surgeons and students.

View Article and Find Full Text PDF

Purpose: Iatrogenic ureteral strictures (US) after endoscopic treatment for urolithiasis represent a significant healthcare concern. However, high-quality evidence on the risk factors associated with US is currently lacking. We aimed to develop a consensus statement addressing the definition, risk factors, and follow-up management of iatrogenic US after endoscopic treatment for urolithiasis.

View Article and Find Full Text PDF
Article Synopsis
  • A systematic review and meta-analysis examined the differences between open radical cystectomy (ORC) and robot-assisted radical cystectomy (RARC) by evaluating data from several randomized controlled trials (RCTs) regarding patient outcomes.
  • The primary focus was on health-related quality of life (QoL) after surgery, with findings showing no significant differences in QoL, complication rates, or oncological outcomes between the two methods at 3 and 6 months post-surgery.
  • RARC had advantages in transfusion rates but required longer operative times and incurred higher costs, making both procedures viable options for treating bladder cancer.
View Article and Find Full Text PDF

Background And Objective: Different training programs have been developed to improve trainee outcomes in urology. However, evidence on the optimal training methodology is sparse. Our aim was to provide a comprehensive description of the training programs available for urological robotic surgery and endourology, assess their validity, and highlight the fundamental elements of future training pathways.

View Article and Find Full Text PDF

Purpose: We aimed to accurately determine ureteral stricture (US) rates following urolithiasis treatments and their related risk factors.

Methods: We conducted a systematic review and meta-analysis following the PRISMA guidelines using databases from inception to November 2023. Studies were deemed eligible for analysis if they included ≥ 18 years old patients with urinary lithiasis (Patients) who were subjected to endoscopic treatment (Intervention) with ureteroscopy (URS), percutaneous nephrolithotomy (PCNL), or shock wave lithotripsy (SWL) (Comparator) to assess the incidence of US (Outcome) in prospective and retrospective studies (Study design).

View Article and Find Full Text PDF
Article Synopsis
  • The study reviews existing research on outpatient endoscopic enucleation of the prostate to assess its feasibility and outcomes for treating benign prostatic obstruction.
  • A thorough literature search identified ten studies for the systematic review, with a total of 1942 patients, and a meta-analysis involving 1228 patients, showing a high success rate for same-day discharge (84%) and a low unplanned readmission rate (3%).
  • The findings suggest that same-day discharge after this procedure is both feasible and safe for well-selected patients, with lower rates of postoperative readmission and complications compared to standard care protocols.
View Article and Find Full Text PDF

Resection Techniques During Robotic Partial Nephrectomy: A Systematic Review.

Eur Urol Open Sci

June 2023

Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy.

Article Synopsis
  • - The study examines various resection techniques in robotic partial nephrectomy (RPN) and their impact on clinical outcomes, highlighting the importance of methodology in achieving optimal results.
  • - A systematic review of 20 studies indicated no major differences in operative metrics like time and blood loss, but enucleation showed advantages in terms of complication rates and recovery time compared to standard resection.
  • - The authors call for standardized definitions and reporting of resection techniques to improve consistency and understanding in the urological field and enhance patient outcomes.
View Article and Find Full Text PDF

Background And Aims: Although dysautonomia is a well-recognized complication of acute demyelinating polyradiculoneuropathy, it is rarely reported and evaluated in chronic demyelinating neuropathies. The purpose of this review is to search and synthesize the current literature on the prevalence and type of autonomic dysfunction (AD) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

Methods: PubMed and Web of Science were searched for studies reporting AD in CIDP.

View Article and Find Full Text PDF

Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy. The molecular mechanisms determining HCM phenotypes are incompletely understood. Myocardial biopsies were obtained from a group of patients with obstructive HCM (n = 23) selected for surgical myectomy and from 9 unused donor hearts (controls).

View Article and Find Full Text PDF

Introduction: Refractory migraine is a particularly disabling form of chronic migraine, unresponsive to multiple prophylactic strategies. Ketogenic diet (KD) is useful to treat migraine but poorly tested for refractory migraine.

Objective: We started exploring the efficacy and safety of KD, as compared to a non-ketogenic dietary regimen similar in reduction of carbohydrate intake (low-carb diet, LCD), in refractory migraine.

View Article and Find Full Text PDF
Article Synopsis
  • * GBS cases from March 2020 to March 2021 showed a 59% increase compared to the previous year, with approximately 50% of GBS patients testing positive for COVID-19.
  • * The study concluded that GBS incidence rose during the pandemic, indicating a significant association between GBS and COVID-19, as non-COVID-19 GBS cases decreased during the same period.
View Article and Find Full Text PDF

Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group.

World J Urol

April 2023

European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group, Arnhem, The Netherlands.

Purpose: To systematically review studies focused on screening programs for renal cell carcinoma (RCC) and provide an exhaustive overview on their clinical impact, potential benefits, and harms.

Methods: A systematic review of the recent English-language literature was conducted according to the European Association of Urology guidelines and the PRISMA statement recommendations (PROSPERO ID: CRD42021283136) using the MEDLINE, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov databases.

View Article and Find Full Text PDF

Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis.

Brain

March 2022

Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132, Milan, Italy.

Phosphorylated TDP-43 (pTDP-43) aggregates in the cytoplasm of motor neurons and neuroglia in the brain are one of the pathological hallmarks of amyotrophic lateral sclerosis. Although the axons exceed the total volume of motor neuron soma by several orders of magnitude, systematic studies investigating the presence and distribution of pTDP-43 aggregates within motor nerves are still lacking. The aim of this study is to define the TDP-43/pTDP-43 pathology in diagnostic motor nerve biopsies performed on a large cohort of patients presenting with a lower motor neuron syndrome and to assess whether this might be a discriminating tissue biomarker for amyotrophic lateral sclerosis and non-amyotrophic lateral sclerosis cases.

View Article and Find Full Text PDF

Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.

Neurology

February 2022

From the Departments of Neurology (A.Y.D., C.W., B.v.d.B., C.V., J.R., S.E.L., K.K., B.C.J.), Public Health (H.F.L.), and Immunology (B.C.J.), Erasmus MC, University Medical Centre Rotterdam; Department of Neurology (C.W., J.P.A.S.), Maasstad Hospital, Rotterdam, the Netherlands; Laboratory of Gut-Brain Signaling (B.I., N.P., Z.I.), Laboratory Sciences and Services Division, Dhaka, Bangladesh; Department of Neurology (A.D., G. Chavada, H.J.W.), College of Medical, Veterinary and Life Sciences, University of Glasgow, UK; Department of Neurology (Y.Y., S. Kusunoki), Kindai University Faculty of Medicine, Osaka-Sayama City, Osaka, Japan; Department of Neurology (M.M.D.), University of Kansas Medical Center, Kansas City; Department of Neurology (W.W., N.K.), University of Vermont Medical Centre, Burlington; National Institute of Neurosciences and Hospital (Q.D.M.), Agargoan, Bangladesh; Department of Neurology (T.H.), Aarhus University Hospital; Department of Neurology (S.H.S.), Odense University Hospital and University of Southern Denmark, Odense, Denmark; Department of Neurology, Neuromuscular Unit (C.C.), Bellvitge University Hospital-IDIBELL, CIBERER, Barcelona, Spain; Department of Neurology (K.B.), Groote Schuur Hospital, University of Cape Town, South Africa; Department of Neurology (J.A.L.M.), Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK; Department of Neurology (B.v.d.B., C.J.G.), Franciscus Vlietland Hospital, Schiedam, the Netherlands; Department of Neurology (L.B.), IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Neurology (S. Kuwabara), Chiba University, Japan; Department of Neurology (P.V.d.B.), Neuromuscular Reference Centre, University Hospital Saint-Luc, University of Louvain, Brussels, Belgium; Department of Neurology (S.M.), Hospital de Pediatría J.P. Garrahan, Buenos Aires, Argentina; Dysimmune Neuropathies Unit, Department of Systems Medicine (G.A.M.), Tor Vergata University Hospital, Rome, Italy; Department of Medicine (N.S.), University of Malaya, Kuala Lumpur; Department of Neurology (G.G.), University Hospital of Modena, Italy; Department of Clinical Neurophysiology, Reference Centre for NMD (Y.P.), CHU Nantes, France; Department of Neurology (J.B.), Saarland University Medical School, Homburg-Saarland (previous affiliation); MVZ Pfalzklinikum (J.B.), Kusel, Germany (current affiliation); Department of Neurology (K.K., R.P.K.), Albert Schweitzer Hospital, Dordrecht, the Netherlands; Department of Neurology (C.M.), Hospital Británico, Buenos Aires, Argentina; Department of Neurology (M.J.S.T.), Hospital Marques de Valdecilla, Santander; Department of Neurology (L.Q., I.I.), Hospital de la Santa Creu i Santa Pau, U.A.B. CIBERER and ERN-NMD, Barcelona, Spain; Department of Neurology (Y.W.), Affiliated Hospital of Jining Medical University, Shandong Province, China; Neuromuscular and Neuroimmunology Service (E.N.-O.), IRCCS Humanitas Clinical and Research Institute, Milan University, Rozzano, Italy; Nuffield Department of Clinical Neurosciences (S.R.), University of Oxford and Oxford University Hospitals NHS Foundation Trust, UK; Department of Neurosciences, Ophthalmology, Rehabilitation, Genetics and Maternal Sciences (A.S.), University of Genova; IRCCS San Martino Hospital (A.S.), Genova, Italy; Department of Neurology (J.P.), Hospital Clínico de Santiago, Santiago de Compostela (A Coruña), Spain; Department of Neurology (F.H.V.), Franciscus Vlietland Hospital (location: Franciscus Gasthuis), Rotterdam, the Netherlands; Department of Neurology (H.C.L.), University Hospital of Cologne, Germany; Department of Neurology (V.G.), Montefiore Medical Centre, Bronx, NY; Department of Neurology (G. Cavaletti), University Milano-Bicocca, Monza, Italy; Department of Neurology (G.G.-G.), Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Spain; Department of Neurology (F.A.B.), Instituto de Investigaciones Neurológicas Raúl Carrea, Buenos Aires, Argentina; Department of Neurology (L.H.V.), St. Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands; Department of Neurology (H.D.K.), University Health Network, University of Toronto, Canada; Department of Neurology (E.D.), University Hospital of Larissa, Greece; Department of Neurology, Reference Centre for NMD (S.A.), CHU Timone, Marseille, France; Department of Neurology (A.J.v.d.K., F.E.), Amsterdam University Medical Centre, University of Amsterdam, Neuroscience Institute, Netherlands Neuromuscular Centre, Euro-NMD; Department of Neurology (P.W.W.), Haga Hospital, Den Haag; Department of Neurology (H.J.G.), Reinier de Graaf Hospital, Delft, the Netherlands; Department of Neurology (R.D.M.H.), King's College Hospital, London; Department of Neurology (J.K.L.H.), The Walton Centre, Liverpool, UK; Department of Neurology (K.A.S.), University of Texas Health Science Centre at Houston; Department of Neurology (S. Karafiath), University of Utah School of Medicine, Salt Lake City; Department of Neurology (M.V.), Lahey Hospital and Medical Center, Tufts University School of Medicine, Burlington, MA; Department of Neurology (G.A.), Mental Health and Sensory Organs (NESMOS), University of Rome "Sapienza," Sant'Andrea Hospital, Rome, Italy; Department of Clinical Neurosciences (T.E.F.), University of Calgary, Canada; Department of Neurology (C.G.F.), Maastricht University Medical Centre, the Netherlands; Department of Neurology (M.B.), Leeds Teaching Hospitals; Department of Neurology (R.C.R.), Addenbrooke's Hospital, Cambridge, UK; Department of Neurology (N.J.S.), University at Buffalo Jacobs School of Medicine and Biomedical Sciences, NY; Department of Neurology (R.F.), Scientific Institute San Raffaele, Milan, Italy; Department of Neurology (G.W.v.D.), Canisius Wilhelmina Hospital, Nijmegen; Department of Neurology (M.P.J.G.), Jeroen Bosch Hospital, 's-Hertogenbosch; Department of Neurology (C.S.M.S.), Leiden University Medical Centre, the Netherlands; and Department of Neurology (K.C.G.), St. Elizabeth's Medical Centre, Tufts University, School of Medicine, Boston, MA.

Article Synopsis
  • The study looked at a score called mEGOS that helps predict if people with a sickness called Guillain-Barré syndrome (GBS) will be able to walk on their own or not.
  • Researchers used information from 1,500 patients from a big study to see if mEGOS worked well for people from different regions and made some improvements to it.
  • The updated score showed good results in different areas, but some places had better or worse outcomes than expected, and they found that things like age and how weak someone’s limbs were were important for predicting problems.
View Article and Find Full Text PDF

Objectives: Nowadays, Robotic assistedkidney transplantation (RAKT) is considered a lessinvasive alternative to the Open Kidney Transplantation(OKT) with several advantages such as image magnification,3D vision and articulated instruments and with arelatively short learning curve for an experienced surgeon.RAKT has shown comparable outcomes with theOKT literature data in terms of surgical and functionalresults. RAKT may decrease the complication rate, meanhospital stay, postoperative pain, and also improve aestheticoutcomes.

View Article and Find Full Text PDF

Background: Kidney autotransplantation is a useful technique to be reserved for cases in which kidney function is compromised by a complex anatomical configuration, such as long ureteral strictures and renal vascular anomalies not suitable for in situ reconstruction. Robot-assisted kidney autotransplantation (RAKAT) presents a novel, minimally invasive, and highly accurate approach.

Objective: The aim of this study is to present the largest cohort of patients who underwent either extracorporeal (eRAKAT) or intracorporeal (iRAKAT) RAKAT, to confirm safety and feasibility and to compare the two approaches.

View Article and Find Full Text PDF

Purpose Of Review: In recent years, there has been an intense debate in literature regarding the definition of the individual variants of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), their possible pathogenetic mechanisms, and impact in the diagnosis of CIDP.

Recent Findings: The 2021 European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) guidelines revised the definition of the individual CIDP variants and implemented their diagnostic criteria. Diagnosis of atypical CIDP is challenging and misdiagnosis is frequent, leading to diagnostic delay and consequent greater accumulation of disability and treatment dependency.

View Article and Find Full Text PDF

Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP.

J Neurol

February 2022

Department of Neuroscience, Reproductive Sciences and Odontostomatology, University of Naples "Federico II", Via Pansini, 5, 81025, Naples, Italy.

Compression of the median nerve at the carpal tunnel can give demyelinating features and result in distal motor latency (DML) prolongation fulfilling the EFNS/PNS demyelinating criteria for chronic inflammatory demyelinating polyneuropathy (CIDP). Accordingly, being carpal tunnel syndrome (CTS) common in the general population, the EFNS/PNS guidelines recommend excluding the DML of the median nerve when DML prolongation may be consistent with median neuropathy at the wrist from CTS. The main aims of this study were to verify whether the inclusion of DML of the median nerve (when consistent with CTS) could improve electrophysiological diagnostic accuracy for CIDP and if the median nerve at the carpal tunnel was more prone to demyelination.

View Article and Find Full Text PDF